About Daniel Cartwright
Daniel Cartwright is a chief financial officer at Pleopharma.
Daniel Cartwright reports to the SEC as an officer of 1 public company: TherapeuticsMD (TXMD).
Daniel Cartwright first appears on SEC filings in 2011.
Experience
This experience comes from Daniel Cartwright's profile and from SEC filings. For roles taken from filings, the years are when the filings name Daniel Cartwright in the role, so the role may have started earlier or lasted longer.
Pleopharma, Inc. Current
Chief Financial Officer
2020 – Present · Phoenixville, PA
Develops a drug for adults experiencing cannabis withdrawal.
TI
TherapeuticsMD, Inc.
Chief Financial Officer
2011 – 2020 · Public company (TXMD)
AT
ATCi
Director
2000 – 2013
PR
PriMetrica
Director
2003 – 2011
CV
Circle F Ventures
Vice President
1996 – 2011
CB
Copper Star Bank
Director
2003 – 2010
CO
CommPartners
Director
2003 – 2010
AW
American Wireless
CFO
1992 – 1996
CS
Community Care Services
Controller
1989 – 1992
DA
Daniels & Associates
Consultant
1984 – 1989
PW
Price Waterhouse
CPA
1982 – 1984
KP
KPMG
CPA
1980 – 1982
Key Colleagues at Startups
The people Daniel Cartwright works with at each company, as listed on that company's latest Form D.
Pleopharma, Inc. · Form D, Aug 10, 2026
KT
Kyle Tomlin
Director
GC
Ginger Constantine
Executive officer and director
SH
Sarah Hassan
Director
JC
Jay Constantine
Chief Medical Officer, Co-Founder and Director
MT
McInerney Timothy
Director
TP
Thomas Poche
Executive officer
RF
Robert Finizio
Executive Director
PB
Paul Bisaro
Director
TT
Tommy Thompson
Director
KM
Kyle Mowitz
Director
BS
Brij Sharma
Director